Union internationale motonautique
UIM
History
Organigram
President
UIM NATIONAL AUTHORITIES AND OTHER AFFILIATED UIM MEMBERS
What is the UIM
Calendar
Anti-Doping
About Anti-Doping - Clean Sport
Documents and Regulations
Important Definitions
REPORT DOPING
Risks of Supplement Use
SANCTIONS & REPORTS
Testing
The Prohibited List
TUE
Whereabouts, RTP/TP & ADAMS
Competitions
Standing & Points
Homologations
records
Champions
Cards
Documents
2024 INTERNATIONAL RACING LICENCES
Disciplinary sanctions
OFFICIAL FORMS / PROCEDURES
PROPSTARS
RULE CHANGE PROPOSALS
RULEBOOKS
Safety
EDUCATION
Youth Development Programme
UIM Environmental Programme
Sustainability
Media
Photo Gallery
Video Gallery
NewsLetter
Press release
UIM Yearbook
Press Review
Home page
private area
Forgot password ?
Anti-Doping
Therapeutic Use Exemptions
RadEditor - HTML WYSIWYG Editor. MS Word-like content editing experience thanks to a rich set of formatting tools, dropdowns, dialogs, system modules and built-in spell-check.
RadEditor's components - toolbar, content area, modes and modules
Toolbar's wrapper
Content area wrapper
RadEditor hidden textarea
%3cp style%3d%22text-align%3a center%3b margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b%22%3e%3cspan style%3d%22background-color%3a %2365be62%3b color%3a %2365be62%3b%22%3e%3cstrong%3e%3cspan style%3d%22font-size%3a 20px%3b color%3a %230e2244%3b%22%3e%3cstrong style%3d%22font-size%3a 18px%3b%22%3e%3cspan style%3d%22background-color%3a %230e2244%3b color%3a %2365be62%3b%22%3e%3cstrong%3e%3cspan style%3d%22font-size%3a 20px%3b color%3a %2365be62%3b%22%3e%26nbsp%3b %26nbsp%3b %26nbsp%3b %26nbsp%3bTHERAPEUTIC USE EXEMPTIONS%26nbsp%3b %26nbsp%3b %26nbsp%3b %26nbsp%3b%3c/span%3e%3c/strong%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a medium%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3chr style%3d%22margin-left%3a 40px%3b%22 /%3e %3cp%3e %3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a medium%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3e %3c/span%3e%3c/strong%3e%3c/span%3e %3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%26nbsp%3b%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a medium%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWHAT IS A %3cspan style%3d%22font-size%3a 11pt%3b font-family%3a %27Times New Roman%27%3b color%3a %23474747%3b%22%3e%3c/span%3eTHERAPEUTIC USE EXEMPTION %28TUE%29%3f%26nbsp%3b%3c/span%3e%3c/strong%3e%3cbr /%3e %3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eAthletes may have illnesses or conditions that require them to take medications or undergo procedures. %3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eIf the medication or method an athlete is required to use to treat an illness or condition is prohibited as per the World Anti-Doping Agency%26rsquo%3bs %28WADA%29 %3ca href%3d%22https%3a//www.wada-ama.org/en/prohibited-list%22%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3cstrong%3eProhibited List%3c/strong%3e%3c/span%3e%3c/a%3e a TUE may give that athlete the authorization to use that substance or method while competing without invoking an anti-doping rule violation %28ADRV%29 and applicable sanction. %3cspan style%3d%22white-space%3a pre%3b%22%3e%3c/span%3e%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eApplications for TUEs are evaluated by a panel of physicians%2c the TUE Committee %28TUEC%29.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 13px%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3ch4 style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3c/h4%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-weight%3a bold%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWHAT ARE THE CRITERIA FOR GRANTING A TUE %3f%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eAll of the four following criteria must be met %28for more details%2c please refer to the %3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3cstrong%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/resources/therapeutic-use-exemption-tue/international-standard-for-therapeutic-use-exemptions-istue%22%3eWADA International Standard for Therapeutic Use Exemptions %28ISTUE%29 Article 4.2%3c/a%3e%3c/strong%3e%3c/span%3e%29%3a%3c/span%3e%3c/p%3e %3cul%3e %3cli style%3d%22text-align%3a left%3b margin-left%3a 80px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eThe athlete has a clear diagnosed medical condition which requires treatment using a prohibited substance or method%3b%3c/span%3e%3c/li%3e %3c/ul%3e %3cul%3e %3cli style%3d%22text-align%3a left%3b margin-left%3a 80px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eThe therapeutic use of the substance will not%2c on the balance of probabilities produce significant enhancement of performance beyond the athlete%26rsquo%3bs normal state of health%3b%3c/span%3e%3c/li%3e %3c/ul%3e %3cul%3e %3cli style%3d%22text-align%3a left%3b margin-left%3a 80px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eThe prohibited substance or method is an indicated treatment for the medical condition%2c and there is no reasonable permitted therapeutic alternative%3b%3c/span%3e%3c/li%3e %3c/ul%3e %3cul%3e %3cli style%3d%22text-align%3a left%3b margin-left%3a 80px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eThe necessity to use that substance or method is not a consequence of the prior use %28without a TUE%29%2c of a substance or method which was prohibited at the time of use.%3c/span%3e%3c/li%3e %3c/ul%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3cspan style%3d%22font-weight%3a bold%3b font-size%3a large%3b font-family%3a %27Segoe UI%27%3b color%3a %2365be62%3b%22%3eWHO SHOULD APPLY FOR A TUE TO THE UIM%2c WHERE AND WHEN %3f%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eAthletes who are subject to anti-doping rules would need a TUE to take a prohibited substance or use a prohibited method. You should verify with UIM to know to whom you need to apply and if you can apply %3cspan style%3d%22white-space%3a pre%3b%22%3e %3c/span%3e%26nbsp%3b %26nbsp%3b %26nbsp%3b %26nbsp%3b %26nbsp%3b %26nbsp%3b retroactively.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eFirst%2c check if the required medication or method you intend to take%2c or use is prohibited as per the %3ca href%3d%22https%3a//www.wada-ama.org/en/prohibited-list%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eWADA Prohibited List.%3c/span%3e%3c/strong%3e%3c/a%3e%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eOr ask your National Anti-Doping Organization %28NADO%29 if it has one %28the list of NADOs is available at%26nbsp%3b%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/code-signatories%23GovernmentFundedOrganizations%22%3ehttps%3a//www.wada-ama.org/en/code-signatories%23GovernmentFundedOrganizations%3c/a%3e%3c/span%3e%3c/strong%3e%29.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eYou have a responsibility to inform your physician%28s%29 that you are an Athlete bound to anti-doping rules. You and your physician%28s%29 should check the %3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/prohibited-list%22%3eProhibited List%3c/a%3e%3c/span%3e%3c/strong%3e for the substance/method you are prescribed. If the %26nbsp%3b substance/method is prohibited%2c discuss non-prohibited alternatives%2c if there are none%2c apply for a TUE.%26nbsp%3b Remember Athletes have the ultimate responsibility. Contact your NADO or%26nbsp%3bUIM if you are having difficulties%3c/span%3e.%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eThen%2c %3cspan style%3d%22font-size%3a 17.9999px%3b font-family%3a MyriadPro-Regular%2c Arial%3b color%3a %23003063%3b%22%3e%3c/span%3e%3c/span%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3echeck your status below%2c to determine your competition level and TUE application requirements%3a%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eInternational-Level Athletes %28Pilots/Drivers%29 Definition%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%28a%29 Pilots/Drivers taking part in any competition registered on the UIM International Sporting Calendar%2c which is published at the following link%3a%26nbsp%3b%3ca href%3d%22https%3a//www.uim.sport/CalendarList.aspx%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3ehttps%3a//www.uim.sport/CalendarList.aspx%3c/span%3e%3c/strong%3e%3c/a%3e%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%28b%29 Drivers included in the UIM Registered Testing Pool%2c the UIM Testing Pool or any other Pool established by the UIM.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%3cstrong%3e%3d%3d%26gt%3b%26nbsp%3b%3c/strong%3e%3c/span%3e%3cspan style%3d%22font-size%3a 14px%3b text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3cstrong%3eIf it is determined that you are an International-Level Athlete %28Pilots/Drivers%29 %22%3cem%3esee definition here above%22%3c/em%3e%3c/strong%3e%3c/span%3e%26nbsp%3byou must apply to UIM in advance%2c as soon as the need arises%2c unless there are emergency or exceptional circumstances.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eFor substances prohibited in-competition only%2c you should apply for a TUE at least 30 days before your next competition%2c unless one of the exceptions on retroactive TUEs %28see below%29 apply.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3ePlease refer to the section %26ldquo%3b%3cem%3eHow to apply to UIM for a TUE%3c/em%3e%3f%26rdquo%3b below.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eIf you already have a TUE granted by any National Anti-Doping Organization %28NADO%29 for any substaces%2c the UIM may automatically recognize it with the need to review it from the UIM TUEC%2c%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3ePlease refer to the section %22%3cem%3eHow to submit a request for recognition of your Nado%27s TUE to the UIM%3c/em%3e%22%29%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b font-size%3a 16px%3b%22%3e%3cstrong%3e%3cspan style%3d%22color%3a %23ff0000%3b%22%3ePlease notify UIM that you have a TUE granted by your NADO%2c even if UIM automatically recognize it %21%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3d%3d%26gt%3b %3cspan style%3d%22text-decoration%3a underline%3b%22%3eIf you are NOT an International-Level Athlete %28Pilots/Drivers%29 and you have been tested by UIM%2c%3c/span%3e%3c/strong%3e%26nbsp%3bthe UIM recognizes a valid TUE granted by your NADO %28%3cspan style%3d%22font-size%3a 14px%3b text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b%22%3eplease refer to the section %22%3c/span%3e%3cem style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 14px%3b text-align%3a justify%3b%22%3eHow to submit a request for recognition of your Nado%27s TUE to the UIM%3c/em%3e%3cspan style%3d%22font-size%3a 14px%3b text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b%22%3e%22%29%26nbsp%3b%3c/span%3e%3c/span%3e%3cspan style%3d%22text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b%22%3eunless you are required to apply for recognition of the TUE because you are competing in an international event.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3eIf you are also not a National-Level Athlete as defined by your NADO%2c you must apply for a retroactive TUE after being tested by the UIM.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3cspan style%3d%22font-weight%3a bold%3b font-family%3a %27Segoe UI%27%3b%22%3e%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-weight%3a bold%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3eCAN I GET A RETROACTIVE TUE%3f%3c/span%3e%3c/p%3e %3cdiv style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22color%3a %23c00000%3b font-family%3a %27Segoe UI%27%3b%22%3e%3c/strong%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eYou may only apply retroactively for a TUE to the UIM%27s TUEC%26nbsp%3bif%3a%3c/span%3e%3c/p%3e %3cul style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 1.1rem%3b padding%3a 0px%3b font-size%3a 14px%3b line-height%3a 1.5%3b list-style-position%3a outside%3b font-family%3a MyriadPro-Regular%2c Arial%3b outline%3a none%3b color%3a %23003063%3b%22%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eYou required emergency or urgent treatment of a medical condition.%3c/span%3e%3c/li%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eThere was insufficient time%2c opportunity or other exceptional circumstances that prevented you from submitting the TUE application%2c or having it evaluated%2c before getting tested.%3c/span%3e%3c/li%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eYou are a lower level driver/pilot who is not under the jurisdiction of the UIM or NADO and were tested.%26nbsp%3b%3c/span%3e%3c/li%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eYou tested positive after using a substance out-of-competition that is only prohibited in-competition %28e.g. glucocorticoids%29.%26nbsp%3b%3c/span%3e%3c/li%3e %3c/ul%3e %3cp%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eIn rare and exceptional circumstances and notwithstanding any other provision in the ISTUE%2c%26nbsp%3byou may apply for and be granted retroactive approval for a therapeutic use of a prohibited substance or method%2c if considering the purpose of the Code%2c it would be manifestly unfair not to grant a retroactive TUE.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem%3b padding%3a 0px%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThis unique retroactive TUE will only be granted with the prior approval of WADA %28and WADA may in its absolute discretion agree with or reject the UIM%27s TUEC%26nbsp%3bdecision%29.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin-top%3a 0px%3b margin-right%3a 0px%3b margin-bottom%3a 1.42857rem%3b padding%3a 0px%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3e%3cstrong%3eImportant note%3a%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem%3b padding%3a 0px%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eUsing a prohibited substance or method without a TUE could result in an Anti-Doping Rule Violation.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem%3b padding%3a 0px%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b text-decoration%3a none solid %23000000%3b font-family%3a %27Segoe UI%27%3b color%3a %23000000%3b%22%3eIn case an application for a retroactive TUE is necessary following sample collection%2c you are strongly advised to have a medical file prepared and ready to submit for evaluation.%26nbsp%3b%3c/span%3e%3c/p%3e %3c/div%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-weight%3a bold%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3eHOW TO APPLY TO THE UIM FOR THE TUE %3f%3c/span%3e%3cstrong style%3d%22color%3a %23c00000%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe UIM encourages TUE applications to be submitted via ADAMS please follow the link here below%2c together with the required medical information. If you do not have an ADAMS account yet%2c contact %3ca href%3d%22mailto%3aantidoping@uim.sport%22%3e%3cstrong%3e%3cem%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eantidoping@uim.sport%3c/span%3e%3c/em%3e%3c/strong%3e%3c/a%3e%26nbsp%3bto set one up.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/athletes-support-personnel/therapeutic-use-exemptions-tues%22%3ehttps%3a//www.wada-ama.org/en/athletes-support-personnel/therapeutic-use-exemptions-tues%3c/a%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3ca href%3d%22https%3a//adams-help.wada-ama.org/hc/en-us/articles/360018982959-Requesting-a-TUE-Recognition%22%3e%26nbsp%3b%3c/a%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b%22%3eAlternatively%2c download the%26nbsp%3b%3ca target%3d%22_blank%22 href%3d%22/Documents/Editor/documents/Anti-doping/TUE/TUE Application Form as from 2021 - form.pdf%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eUIM%26rsquo%3bs TUE Application Form%3c/span%3e%3c/strong%3e%3c/span%3e%3c/a%3e%26nbsp%3band once duly completed and signed%2c send it together with the required medical file to%26nbsp%3b%3ca href%3d%22mailto%3atue@ita.sport%22 style%3d%22box-sizing%3a border-box%3b color%3a %2300b4e1%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cspan style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3c/span%3e%3c/a%3e%3ca href%3d%22mailto%3aantidoping@uim.sport%22 style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 14px%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3cem%3eantidoping@uim.sport%3c/em%3e%3c/span%3e%3c/strong%3e%3c/a%3e%3c/span%3e%3cspan style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3cem%3e.%3c/em%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eYour TUE application must be submitted in legible capital letters or completed electronically.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe medical file must include%3a%3c/span%3e%3c/p%3e %3cul style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-size%3a 14px%3b line-height%3a 1.5%3b list-style-position%3a outside%3b font-family%3a MyriadPro-Regular%2c Arial%3b outline%3a none%3b%22%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eA comprehensive medical history%2c including documentation from the original diagnosing doctor%28s%29 %28where possible%29%3b%3c/span%3e%3c/li%3e %3cli style%3d%22box-sizing%3a border-box%3b margin%3a 0px%3b padding%3a 0px%3b outline%3a none%3b font-size%3a 1.28571rem%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe results of all examinations%2c laboratory investigations and imaging studies relevant to the application.%3c/span%3e%3c/li%3e %3c/ul%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eAny costs incurred by the Pilot/Driver in relation to the TUE application and in order to supplement it as required by the TUEC are the responsibility of the Pilot/Driver.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eAny TUE application that is not complete or legible will be returned for completion and re-submission.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eTo assist you and your doctor in providing the correct medical documentation%2c we suggest consulting WADA%26rsquo%3bs%26nbsp%3b%3ca href%3d%22https%3a//www.wada-ama.org/en/resources/world-anti-doping-program/guidelines-international-standard-therapeutic-use-exemptions%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eChecklists for TUE applications%3c/span%3e%3c/strong%3e%3c/a%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/resources/search%3ff%255B0%255D%3dfield_resource_collections%253A225%26amp%3bf%255B1%255D%3dfield_resource_versions%25253Afield_resource_version_language%253A91%22%3e%26nbsp%3b%3c/a%3e%3c/span%3e%3c/strong%3efor guidance and support%2c and%26nbsp%3b%3ca href%3d%22https%3a//www.wada-ama.org/en/news/wada-publishes-updated-therapeutic-use-exemption-physician-guidelines-and-checklists%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eMedical Information to Support the Decisions of TUECs%3c/span%3e%3c/strong%3e%3c/a%3e%26nbsp%3bfor guidance on specific common medical conditions%2c treatments%2c substances%2c etc.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eKeep a complete copy of the TUE application form and all medical information submitted in support of your application%2c and proof that it has been sent.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a left%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3e%26nbsp%3b%3c/span%3e%3cspan style%3d%22text-align%3a justify%3b font-weight%3a 700%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3eHOW TO SUBMIT A REQUEST FOR RECOGNITION OF YOUR NADO%27S TUE TO THE UIM %3f%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe UIM%27s TUEC may automatically recognise your NADO TUE %28even if it is not insert to ADAMS%29 for purposes of international-level competition with the need to review the relevant clinical information. Nevertheless%2c please inform us when you make an application for a NADO TUE %28that will be not inserted into ADAMS%29.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eYou can download your TUE certificate directly from ADAMS.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22text-align%3a justify%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3e%3cstrong%3eWHAT HAPPENS AT MAJOR EVENTS %3f%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eA Major Event Organization %28MEO%29 requires athletes to apply for the recognition of their TUE if they wish to use a prohibited substance or method in connection with the Event.%3c/span%3e%3c/p%3e %3cp style%3d%22font-size%3a 1.28571rem%3b box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 10pt%3b font-family%3a %27Segoe UI%27%3b%22%3eIf you have a TUE granted by UIM and you will be competing at a Major Event e.g.%2c the Olympic Games%2c you should contact the MEO for information on their recognition process%3c/span%3e%3c/p%3e %3cdiv%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cbr /%3e %3c/span%3e%3c/div%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-weight%3a bold%3b font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWHEN WILL I RECEIVE A DECISION ON MY TUE APPLICATION %28OR REQUEST FOR RECOGNITION%29 %3f%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eThe UIM%26rsquo%3bs TUEC%26rsquo%3bs decision will be communicated in writing to you within 21 days from the date of receipt of the complete TUE application %5bor request for recognition%5d%2c including the required medical information.%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 18px%3b%22%3e%3cstrong%3e%3cspan style%3d%22color%3a %2365be62%3b%22%3eWHAT IF I NEED TO RENEW MY TUE%26nbsp%3b%3f%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eEach TUE has a specific duration%2c at the end of which it expires automatically. Should you need to continue to use the prohibited substance or method%2c it is your responsibility to submit a new application for a TUE with updated medical information ahead of the expiry date%2c so that there is sufficient time for a decision to be made prior to the expiry of the current TUE.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3eImportant note%3a%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe presence %28following sample collection%29%2c use%2c possession or administration of the prohibited substance or method must be consistent with the terms of your TUE. Therefore%2c if you require a materially different dosage%2c frequency%2c%26nbsp%3brouteor duration of administration%2c you should contact us%2c as%26nbsp%3byou may be required to apply for a new TUE. Some substances and dosages%2c e.g. insulin%2c are often modified during treatment and these possible fluctuations should be mentioned by the treating doctor in the TUE application and are typically accepted by the UIM%27s TUEC.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b color%3a %230e2244%3b%22%3e%3cem%3e%26nbsp%3b%3c/em%3e%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWHAT IF MY UIM%27S TUE APPLICATION IS DENIED %3f%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eA decision to deny a TUE application will include a written explanation of the reason%28s%29 for the denial. If it is not clear to you%2c please contact us to understand exactly why the TUE was denied. Sometimes%2c there may be a critical piece of information%2c diagnostic test%2c laboratory results%2c etc. missing. In which case%2c you should resubmit your application.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eYou and/or your NADO may refer the matter to WADA for review no later than 21 days after notification of the UIM%27s TUEC decision. You should send the same information that you submitted to us%2c and on which the decision to deny the TUE was based%2c via a secure online method or by registered post to%3a%3c/span%3e%3c/p%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eWADA Medical Department%3cbr style%3d%22box-sizing%3a border-box%3b outline%3a none%3b%22 /%3e World Anti-Doping Agency%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eStock Exchange Tower%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3e800 Place Victoria %28Suite 1700%29%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eP.O. Box 120%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eMontreal %28Quebec%29 H4Z 1B7%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eCanada%3c/address%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%26nbsp%3b%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe email address to enquire and/or send the request for review is%3a%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3e%26nbsp%3b%3ca href%3d%22mailto%3amedical@wada-ama.org%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3em%3c/a%3e%3ca href%3d%22mailto%3amedical@wada-ama.org%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3eedical@wada-ama.org%3c/a%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3ePlease note that WADA is not obliged to proceed with a request for a review. In that case%2c you and/or your NADO may appeal to the Court of Arbitration for Sport %28CAS%29.%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWHAT IF MY NADO%27S TUE IS NOT RECOGNIZED BY THE UIM %3f%26nbsp%3b%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eYou and/or your NADO have 21 days from the date of decision to refer the matter to WADA for review. The email address to enquire and/or send the request for review is%3a%26nbsp%3b%3ca href%3d%22mailto%3amedical@wada-ama.org%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3emedical@wada-ama.org%3c/span%3e%3c/strong%3e%3c/a%3e. %3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eAlternatively%2c you may send it to%3a%26nbsp%3b%3c/span%3e%3c/p%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eWADA Medical Department%3cbr style%3d%22box-sizing%3a border-box%3b outline%3a none%3b%22 /%3e World Anti-Doping Agency%3cbr style%3d%22box-sizing%3a border-box%3b outline%3a none%3b%22 /%3e Stock Exchange Tower%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3e800 Place Victoria %28Suite 1700%29%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eP.O. Box 120%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eMontreal %28Quebec%29 H4Z 1B7%3c/address%3e %3caddress style%3d%22margin-left%3a 40px%3b%22%3eCanada%3c/address%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%26nbsp%3b%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eThe same information that was provided to your NADO should be submitted to WADA. Please use a secure online method unless sending by registered post.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3ePending WADA%26rsquo%3bs decision%2c your NADO%3c/span%3e%26nbsp%3bTUE remains valid for national-level%26nbsp%3bcompetition%26nbsp%3band out-of-competition testing only.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eIf the matter is not referred to WADA for review%2c your NADO must determine whether the original TUE that was granted should remain valid for national-level competition%26nbsp%3band out-of-competition testing.%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-weight%3a 500%3b font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3cspan style%3d%22text-align%3a center%3b%22%3e%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eWILL MY MEDICAL INFORMATION BE TREATED IN A CONFIDENTIAL MANNER %3f%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eAll the information contained in a TUE application%2c including the supporting medical information and any other information related to the evaluation of your TUE request is kept strictly confidential and treated in accordance with the Athlete%26rsquo%3bs Declaration contained in the ADAMS TUE and in the TUE application form which can be found%26nbsp%3b%3ca href%3d%22/Documents/Editor/documents/Anti-doping/TUE/TUE Application Form as from 2021 - form.pdf%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3ehere%3c/span%3e%3c/strong%3e%3c/a%3e. All members of the TUEC and any other authorised recipients of your TUE request and related information %28as described in the Athlete%26rsquo%3bs Declaration%29 are subject to a professional or contractual confidentiality obligation.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3ePlease review the terms of the Athlete%26rsquo%3bs Declaration carefully. In particular%2c note that should you wish to revoke the right of the UIM%27s TUEC to obtain the information related to your TUE in accordance with the Athlete%26rsquo%3bs Declaration%2c your TUE application will be deemed withdrawn without approval %28or recognition%29 being granted.%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b font-family%3a %27Segoe UI%27%3b%22%3eInformation related to your TUE request will be retained by the UIM%27s TUEC and any other authorised recipients for no longer than necessary for the purposes stated in the Athlete%26rsquo%3bs Declaration%2c in accordance with the International Standard for the Protection of Privacy and Personal Information.%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b font-size%3a 13px%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eCONTACT INFORMATION%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3eFor any further information and questions in relation to UIM%26rsquo%3bs personal information practices%2c please contact the UIM Anti-Doping Administrator at %3ca href%3d%22mailto%3aantidoping@uim.sport%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eantidoping@uim.sport%3c/span%3e%3c/strong%3e%3c/a%3e.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e If you have a doubt as regards to which organization you should apply for a TUE%2c or as to the recognition process%2c or any other question with regard to TUEs%2c please contact the UIM Anti-Doping Administrator at %3ca href%3d%22mailto%3aantidoping@uim.sport%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b%22%3eantidoping@uim.sport%3c/span%3e%3c/strong%3e%3c/a%3e.%3c/span%3e%3c/p%3e %3cp style%3d%22text-align%3a justify%3b margin-left%3a 40px%3b%22%3e%3cspan style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%26nbsp%3b%3c/span%3e%3c/p%3e %3cp style%3d%22margin-left%3a 40px%3b%22%3e%3cstrong style%3d%22font-family%3a %27Segoe UI%27%3b%22%3e%3cspan style%3d%22font-size%3a 18px%3b color%3a %2365be62%3b%22%3eOTHER USEFUL LINKS%3c/span%3e%3c/strong%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b color%3a %23003063%3b%22%3e%3ca target%3d%22_blank%22 href%3d%22https%3a//www.wada-ama.org/en/resources/therapeutic-use-exemption-tue/international-standard-for-therapeutic-use-exemptions-istue%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b font-family%3a %27Segoe UI%27%3b%22%3eWADA International Standard for Therapeutic Use Exemptions %28ISTUE%29%3c/span%3e%3c/strong%3e%3c/span%3e%3c/a%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22text-decoration%3a underline%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3cspan style%3d%22font-size%3a 14px%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/contact-us%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%26nbsp%3b%3c/a%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/contact-us%22%3eWADA Contact form%3c/a%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3cspan style%3d%22text-decoration%3a underline%3b font-family%3a %27Segoe UI%27%3b%22%3e%3cstrong%3e%3cspan style%3d%22font-size%3a 14px%3b%22%3e%3ca href%3d%22https%3a//www.wada-ama.org/en/resources/therapeutic-use-exemption/checklist-therapeutic-use-exemption-tue-application-general%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3eWADA Checklists for TUE Applications%3c/a%3e%3c/span%3e%3c/strong%3e%3c/span%3e%3c/p%3e %3cp style%3d%22box-sizing%3a border-box%3b margin%3a 0px 0px 1.42857rem 40px%3b padding%3a 0px%3b font-family%3a MyriadPro-Regular%2c Arial%3b font-size%3a 1.28571rem%3b line-height%3a 1.5%3b text-rendering%3a optimizelegibility%3b outline%3a none%3b%22%3e%3ca href%3d%22https%3a//adel.wada-ama.org/%22 style%3d%22box-sizing%3a border-box%3b line-height%3a inherit%3b outline%3a none%3b%22%3e%3cspan style%3d%22font-size%3a 14px%3b%22%3e%3cstrong%3e%3cspan style%3d%22text-decoration%3a underline%3b font-family%3a %27Segoe UI%27%3b%22%3eWADA Anti-Doping Education and Learning %28ADEL%29%3c/span%3e%3c/strong%3e%3c/span%3e%3c/a%3e%3c/p%3e
RadEditor's bottom area: Design, Html and Preview modes, Statistics module and resize handle.
It contains RadEditor's Modes/views (HTML, Design and Preview), Statistics and Resizer
Editor Mode buttons
Statistics module
Editor resizer
Preview
RadEditor - please enable JavaScript to use the rich text editor.
RadEditor's Modules - special tools used to provide extra information such as Tag Inspector, Real Time HTML Viewer, Tag Properties and other.
Log book